Lyt til artiklen
The Danish pharmaceutical Lundbeck’s protests against the use of its product in US executions have fallen on deaf ears and the company has no contractual base upon which to stop its use.
“I know of no contract mechanisms that give a producer the possibility to decide how the end user uses the product,” says Columbia University Law Professor Robert E. Scott, but adds that Lundbeck, in its supplier contract, could distance itself from its medicine being used in executions.
